GenusPlus shares dipped 2.4% following results that highlighted significant revenue growth and milestone EBITDA, but market reaction suggests investor caution over early-stage margin pressures and the integration risks from recent acquisitions.
- Revenue surged 70% to $1.28 billion, driven significantly by infrastructure and the MPK acquisition.
- EBITDA surpassed $100 million, reaching a major profitability milestone.
- Underlying NPAT recorded at $54 million; final dividend declared at $0.036 per share.
- Order book stands at $2.2 billion, excluding some MPK projects that are rolling off.
- Management acknowledged margin pressures and ramp-up challenges on large infrastructure projects, signaling ongoing operational complexity.
Community Discussion